Welcome to our dedicated page for Plexus SEC filings (Ticker: PLXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Plexus Corp (NASDAQ: PLXS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Plexus files periodic and current reports as a Wisconsin corporation with Commission File Number 001-14423.
Among the key documents available are current reports on Form 8-K, which Plexus uses to furnish press releases announcing quarterly and annual financial results. These filings typically include information on revenue, operating margin, earnings per share, non-GAAP performance measures, return on invested capital, free cash flow and other financial metrics, as well as commentary on business conditions and program wins.
Through this page, users can track how Plexus reports its results for fiscal quarters and years, including references to its geographic segments in the Americas, Asia-Pacific and Europe, Middle East and Africa regions, and its focus on Aerospace/Defense, Healthcare/Life Sciences and Industrial market sectors. Filings also confirm corporate details such as state of incorporation and principal corporate location.
Stock Titan enhances these filings with AI-powered summaries that highlight the most important points from lengthy documents, helping readers quickly understand the implications of each report. Real-time updates from the SEC’s EDGAR system, along with structured access to forms such as 8-K and other periodic reports, make it easier to review Plexus’ regulatory history and monitor ongoing disclosures related to PLXS.
Plexus Corp (PLXS) reported an insider transaction by its Exec VP, CAO, General Counsel & Secretary. On 11/10/2025, the officer sold 2,500 shares of common stock, coded “S” for sale, at a weighted average price of $145.2771. Following the sale, the reporting person beneficially owns 20,895 shares, held directly.
The filing notes the sale was executed in multiple trades within a price range of $145.0001 to $145.56 per share, with the weighted average reported. This is a routine Form 4 disclosure of insider activity and does not alter the company’s capital structure.
Plexus Corp. (PLXS) director reported a personal stock transaction. On 11/04/2025, the reporting person made a bona fide gift of 700 shares of Plexus common stock, coded “G.” After this transaction, the reporting person beneficially owns 8,165 shares, held directly.
This filing reflects a charitable or personal transfer and does not indicate a sale for proceeds.
Plexus Corp (PLXS) President & CEO and director Todd P. Kelsey reported open‑market sales of common stock on 11/03/2025, 11/04/2025, and 11/05/2025 pursuant to a Rule 10b5‑1 plan adopted on August 16, 2024. He sold 1,500 shares at $139.12, 2,000 shares at $143.50, and 2,000 shares at $145.10. After these transactions, he beneficially owned 58,714 shares, held directly.
Plexus Corp (PLXS) reported an amended insider filing. A company director filed a Form 4/A to correct the reported equity award to 1,370 Restricted Stock Units granted on 02/03/2025. Each RSU represents a right to receive one share of Plexus common stock under the 2024 Omnibus Incentive Plan. The RSUs vest on February 3, 2026, and the filing lists direct ownership. The amendment states it was filed to correct the number of RSUs granted.
Plexus Corp (PLXS) reported an insider update. Director Michael V. Schrock filed a Form 4/A amending a prior report to reflect the acquisition of 1,370 restricted stock units on February 3, 2025 under the Plexus Corp. 2024 Omnibus Incentive Plan.
Each RSU represents the right to receive one share of Plexus common stock. The RSUs vest on February 3, 2026. The amendment states it was filed to correct the number of Restricted Stock Units granted.
Plexus Corp (PLXS) reported an amended insider filing. A company director filed a Form 4/A to correct the size of a previously reported equity award to 1,370 Restricted Stock Units granted on 02/03/2025 under the Plexus Corp. 2024 Omnibus Incentive Plan, reported with transaction code A.
Each RSU represents a contingent right to receive one share of Plexus common stock and vests on 02/03/2026. Following the transaction, 1,370 derivative securities were beneficially owned directly. The amendment notes the change was made to correct the number of RSUs granted.
Plexus Corp (PLXS) reported a Form 4/A by Director Karen Rapp amending a prior filing to correct the size of a restricted stock unit grant. On February 3, 2025, 1,370 Restricted Stock Units were awarded under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3. Each RSU represents one share of common stock and vests on February 3, 2026. Following the transaction, 1,370 derivative securities were beneficially owned directly.
Plexus Corp (PLXS) disclosed an amended Form 4 for director J. Joel Quadracci, reporting the acquisition of 1,370 Restricted Stock Units on 02/03/2025 under the Plexus Corp. 2024 Omnibus Incentive Plan.
Each RSU represents a contingent right to receive one share of Plexus common stock, and the RSUs vest on 02/03/2026. Following the reported transaction, the filing lists 1,370 derivative securities beneficially owned, held directly. The amendment states it was filed to correct the number of RSUs granted.
Plexus Corp (PLXS) filed a Form 4/A reporting a corrected equity award to a board member. Director Randy J. Martinez received 1,370 Restricted Stock Units on 02/03/2025 under the 2024 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Plexus common stock. The RSUs vest on 02/03/2026. The filing states the amendment was made to correct the number of RSUs granted. Ownership of the derivative securities is reported as Direct.
Plexus Corp. (PLXS) reported an insider update: director Rainer Jueckstock filed an amended Form 4 to correct an equity award. The filing states a grant of 1,370 Restricted Stock Units on February 3, 2025 under the Plexus Corp. 2024 Omnibus Incentive Plan.
Each RSU represents a contingent right to receive one share of Plexus common stock, and the RSUs vest on February 3, 2026. Following the correction, the reporting person shows 1,370 derivative securities held directly. The amendment is expressly to correct the number of RSUs granted.